Rumah Sakit Pusat Angkatan Darat Gatot Soebroto Report issue

Government Phase 1 Phase 2 Phase 4

Organization Overview

First Clinical Trial
2016
NCT03626298
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Dr Irma Bernadette S Sitohang | Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | Rumah Sakit Pusat Angkatan Darat (RSPAD) Gatot Soebroto, Jakarta

Active Ingredients

Drugs in Phase 4 Trials (3)

adapalene (differin) (1 trial)

nicotinamide (1 trial)

zinc sulfate (1 trial)

Drugs in Phase 2 Trials (1)

av-covid-19 (2 trials)

Drugs in Phase 1 Trials (2)

COVID-19 convalescent plasma (1 trial)

glutathione (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 4)

Convalescence (Phase 1)

Coronavirus Infections (Phase 1)

Severe Acute Respiratory Syndrome (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 6